- Meeting abstract
- Open Access
LRET-based distance measurements in the mammalian glutamate transporter EAAT3
© Saha et al; licensee BioMed Central Ltd. 2012
- Published: 17 September 2012
- Xenopus Laevis
- Amino Acid Transporter
- Excitatory Amino Acid
- Glutamate Transporter
- Structural Framework
EAAT3 (excitatory amino acid transporter 3) mediates the regulation of synaptic transmission by reuptake of glutamate in the synaptic cleft. It is distributed in neuronal membranes and is selectively enriched in the neurons of the hippocampus, cerebellum and the basal ganglia. It belongs to the family of soluble carrier family 1 member 1 (SLC1A1) and is expressed in kidney, a wide variety of epithelial tissues, brain and eyes.
The project utilizes the high-resolution crystal structure of GltPh, the bacterial orthologue to mammalian glutamate transporters. GltPh provides a structural framework for the determination of the helical movement in EAAT3. The structural rearrangement of the protein is caused by the helical movements which will be assessed by distance measurements using the technique of lanthanide resonance energy transfer (LRET). The protein will be expressed in Xenopus laevis oocytes. Lanthanide binding tags (LBT) will be inserted into the protein to chelate the lanthanide terbium which serves as the donor element. Cysteines will be reacted to an acceptor dye (bodipy FL).
The measured distances will allow us to obtain new insights into the structure-function relationship of the glutamate transporters which can be further investigated using different substrates and inhibitors.
The results obtained in this project will allow us to better understand pathophysiological conditions associated with mutations in EAAT3, for instance mutations causing human dicarboxylic aminoaciduria.
The study is supported by grants F3506 and W1232 of the PhD program MolTag (Molecular Drug Targets) of the University of Vienna, the Medical University of Vienna and the Vienna University of Technology.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.